Abstract: A compound, or a pharmaceutically acceptable salts or prodrugs thereof, having the chemical structure: and methods of using these compounds to inhibit WEE1 kinase and treat cancer in a subject.

Abstract: The present disclosure provides host cells for reliable, high yield recombinant protein production, including unstable proteins. The present host cell (e.g., a bacterial cell) is deficient in at least one protease (or a subunit of a protease) such as Clp or ClpP. The host cell may also contain an expression vector that encodes a protein or polypeptide for overexpression.

Abstract: Compositions comprising Group V/III nanowires, and methods of making such nanowires are described. Some compositions comprise one or more core-shell nanowires comprising a core and a first shell surrounding or substantially surrounding the core. The core is formed from GaAs(1?y)Sby, where y=about 0.03-0.07 and the first shell is formed from GaAs(1?x)SbxN, where x=0.27-0.34. The nanowires have an average emission maximum of 1.4-1.7 ?m. Some nanowires further comprise a second shell surrounding or substantially surrounding the first shell. The second shell is formed from a Group V/III material such as Ga1?mAlmAs, where m=0-0.2. Some nanowires have the structure GaAs(0.93-0.97)Sb(0.03-0.07)/GaAS(0.66-0.73)Sb(0.27-0.34)N/Ga(0.8-1)Al(0-0.2)As.

Abstract: The disclosure relates to a phase change thermal storage ceramic having high service temperature and improved utilization rate and utilization efficiency of heat. It is prepared at a low cost with a simple, easy-to-industrially-realized method. A mixture is obtained by mixing and stirring evenly 50-85 wt % of fused mullite powder, 10-45 wt % of pretreated aluminum-silicon alloy powder, and 3-8 wt % of ball clay. A ceramic body is formed by press molding the mixture at 80-150 MPa. The ceramic body is cured at 25-28° C. and a relative humidity of 70-75 RH for 24-36 h, dried at 80-120° C. for 24-36 h, and held at 1,100-1,300° C. for 3-5 h to prepare the phase change thermal storage ceramic. The pretreated aluminum-silicon alloy powder is prepared by holding aluminum-silicon alloy powder in water vapor at 0.02-0.20 MPa for 0.5-3 h to impregnate in an alkaline silica sol and drying the impregnated powder.

Abstract: A histotripsy therapy system configured for the treatment of brain tissue is provided, which may include any number of features. In one embodiment, the system includes an ultrasound therapy transducer, a drainage catheter, and a plurality of piezoelectric sensors disposed in the drainage catheter. The ultrasound therapy is configured to transmit ultrasound pulses into the brain to generate cavitation that liquefies a target tissue in the brain. The drainage catheter is configured to detect the ultrasound pulses. An aberration correction algorithm can be executed by the system based on the ultrasound pulses measured by the drainage catheter to automatically correct for an aberration effect caused by the ultrasound pulses passing through a skullcap of the patient.

Abstract: A system for lung assist includes a plurality of fiber bundle sections. Each of the fiber bundle sections includes a fiber bundle housing defining a fiber bundle compartment therein and a fiber bundle positioned within the fiber bundle compartment. The fiber bundle includes a plurality of hollow gas permeable fibers configured to permit diffusion of gas between blood and an interior of the plurality of hollow gas permeable fibers. The plurality of hollow gas permeable fibers is positioned such that blood flows around the plurality of hollow gas permeable fibers when flowing through the fiber bundle compartment. Each fiber bundle is different in at least one property from each other fiber bundle.

Abstract: An isolated bacterial strain of Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 deposited under the DSMZ Accession No. DSM 34213 is provided; a probiotic composition including an Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 and optionally, one or more additional probiotic organisms that enhance the probiotic activity of the Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 is also provided; and a method for preventing or treating chronic kidney disease in a subject in need thereof including: administering to the subject a pharmaceutically effective amount of the probiotic composition including an isolated bacterial strain of Lactiplantibacillus plantarum subsp. plantarum MFM 30-3, and optionally, one or more additional probiotic organisms that enhance the probiotic activity of the Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 is further provided.

Abstract: The present disclosure provides a securement assembly for an enteral access device or vesical access device (“access device”). The securement assembly includes a base and a lid. The base is generally configured to support an external port of the access device and the lid is pivotably coupled to the base. The base comprises a border rim and a central portion, wherein the border rim is configured to engage a skin surface of a patient around a stoma and the central portion is configured to engage the external port of the access device. The central portion may comprise opposing side arms defining an aperture through which a tube of the access device extends.

Abstract: An embodiment includes a system comprising: a substrate of a medical device; an un-foamed polyurethane coating directly contacting the substrate and fixedly attached to the substrate; a thermoset polyurethane shape memory polymer (SMP) foam, having first and second states, which directly contacts the polyurethane coating and fixedly attaches to the polyurethane coating; wherein the polyurethane coating fixedly attaches the SMP foam to the substrate. Other embodiments are described herein.

Abstract: Resource synchronization in an machine-to-machine (M2M) system is disclosed. A method of operating an M2M device may comprise creating a first resource, receiving a first message for requesting an update to the first resource, and transmitting a second message for requesting an update to a second resource to another device hosting the second resource synchronized with the first resource. The first resource may comprise at least one attribute for offloading of a resource.

Abstract: An apparatus and a method of predicting a video frame are provided. The apparatus includes a level encoder configured to extract and learn at least one feature from a video frame, a feature learning unit configured to learn based on the at least one feature or transmit predicted feature data corresponding to the at least one feature, and a level decoder configured to obtain and learn a predicted video frame based on the predicted feature data.

Abstract: Disclosed is a method for synthesizing 1,3,2-dioxathiolane 2,2-dioxide (DTD) by in-situ catalytic oxidation. A titanium silicon (TS)-1 molecular sieve is modified with a Pd salt and an Au salt to obtain an Au—Pd/TS-1 molecular sieve, which catalyzes oxygen and hydrogen to form hydrogen peroxide, and oxidizes glycol sulfite in situ in a reactor to synthesize DTD. An Au—Pd/TS-1 molecular sieve catalyst prepared by the present disclosure, which has two catalytic activities of catalytic synthesis of hydrogen peroxide and catalytic oxidation of sulfite, can significantly increase the reaction rate, enable the complete conversion of raw materials in a shorter residence time, and effectively inhibit the hydrolysis of products, and a high-purity DTD product can be obtained by washing and evaporatively crystallizing an organic phase.

Abstract: A lightweight radiation shielding material. A carbon nanotube forest is embedded in a matrix comprising nanoparticulates, such as nanoparticles, carbon nanotubes, or graphene nanosheets. The nanoparticulates can be low atomic number (low-Z) or high atomic number (high-Z). The matrix can be a solidified polymer, epoxy, resin, or ceramic precursor, for example silicon carbide. The radiation shield can shield an object from radio frequency interference (RFI), lightning, electromagnetic interference (EMI), an electromagnetic pulse (EMP), gamma rays, X-rays, neutrons, and/or protons. The nanoforest is disposed on a conductive base with sufficient in-plane electrical conductivity to provide an effective conductive path for currents induced by radiation absorption. The base can be a second nanoforest comprising horizontally-oriented carbon nanotubes, which makes the shield particularly lightweight, as low as 10% of the mass of aluminum that provides equivalent shielding.

Abstract: Therapeutic antibodies having binding specificity for ROR-1 expressed on cancer cells (particularly leukemic and lymphomic cells) and pharmaceutical compositions containing one or more such antibodies for use in treating cancer. Methods for diagnosing such cancers through in vitro detection of binding to ROR-1 protein expressed on putative cancer cells are also provided.

Abstract: Provided are nanopore devices that include a hafnium oxide coating on the pores of the devices. Such devices exhibit improved stability, especially when in a salt solution environment. Also provided are related methods.

Abstract: A light emitting device includes a first electrode, a hole transporting layer in contact with the first electrode, a second electrode, an electron transporting layer in contact with the second electrode; and an emissive layer between the hole transporting layer and the electron transporting layer. The emissive layer includes a metal-assisted delayed fluorescent (MADF) emitter, a fluorescent emitter, and a host, and the MADF emitter harvests electrogenerated excitons and transfers energy to the fluorescent emitter.

Abstract: Embodiments of the disclosure concern compositions and methods of use related to particular c-kit+ mesenchymal cells, including cardiac stem cells, obtained from a pediatric or neonatal individual. In specific embodiments, the cells, or conditioned medium or partial or total secretomes thereof, are provided in an effective amount to an individual in need thereof.

Abstract: The present invention pertains to a pharmaceutical composition for the prevention or treatment of kidney disease, a kidney inflammation inhibitor, an inflammatory cell death inhibitor for the kidneys, or a food for the prevention or improvement of kidney disease, that include D-alanine or a derivative thereof. In addition, the present invention pertains to the use of D-alanine or a derivative thereof, for the production of a pharmaceutical composition for the prevention or treatment of kidney disease.

Abstract: The present invention relates to the discovery of novel PLGA particles comprising a polypeptide adsorbed on the surface of the PLGA particles. In certain embodiments, the PLGA particles can be used to administer the polypeptide to a patient in need thereof. As compared to polypeptide-delivery formulations known in the art, the present invention demonstrates a higher relative polypeptide loading capacity. In certain embodiments, the polypeptide adsorbed on the surface of the PLGA nanoparticles does not denature or deform upon adsorption.

Abstract: Disclosed are a sorbent produced by recycling waste paper, which is an eco-friendly recycling paper resource, to adsorb and remove a marine spilled oil and other types of oil and a method of producing the same. The oil sorbent is produced by hydrophobizing a biomass material such as waste paper using a gas-grafting method. Compared to the oil sorbent of the prior art formed of synthetic resin, it is possible to provide excellent oil adsorption selectivity, a high oil adsorption rate, and a low water absorption rate. Therefore, an incineration process for processing the waste oil sorbent after use is easy advantageously. The oil sorbent generates less harmful substances during combustion because the eco-friendly material is used. Since a biomass material is hydrophobized using vegetable fatty acids, decomposition is performed fast within a short time in a landfill process, and there is no risk of environmental pollution.